TCS 359

CAS No. 301305-73-7

TCS 359( TCS359, TCS 359, TCS-359 )

Catalog No. M17469 CAS No. 301305-73-7

TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 28 In Stock
10MG 43 In Stock
25MG 85 In Stock
50MG 142 In Stock
100MG 185 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TCS 359
  • Note
    Research use only, not for human use.
  • Brief Description
    TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM.
  • Description
    TCS-359 is a potent inhibitor of FLT3 with IC50 of 42 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TCS359, TCS 359, TCS-359
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    FLT3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    301305-73-7
  • Formula Weight
    360.43
  • Molecular Formula
    C18H20N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 14.29 mg/mL 39.65 mM;
  • SMILES
    COC1=CC=C(C=C1OC)C(=O)NC1=C(C(N)=O)C2=C(CCCC2)S1
  • Chemical Name
    2-(3,4-dimethoxybenzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Raymond J. Patch, et al. Bioorg Med Chem Lett, 2006, 16(12), 3282-3286.
molnova catalog
related products
  • K-111

    K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.

  • Siramesine

    Siramesine(Lu 28-179) is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.

  • CC618

    CC618 is a selective PPARβ/δ antagonist with an IC50 of 10.0 μM.